News Events & Articles

From Margins to Mainstream: Including Underrepresented Patients in RWE August 28, 2025 📉 Underserved. Underdiagnosed. Underrepresented. That’s the reality for millions of patients missing from real-world evidence.   They don’t show up in the claims. They’re undercoded in EHRs. They’re overlooked in traditional cohort designs.   And when they’re invisible to your data, they’re invisible […]

Auto-inflammatory awareness month August 26, 2025 🧡August is Autoinflammatory Disease Awareness Month!    Did you know that autoinflammatory diseases are rare, often misunderstood conditions where the immune system causes inflammation by attacking the body itself? These diseases can be difficult to diagnose and manage, impacting patients and families in profound ways.   🔍 A major

Spinal Muscular Atrophy Awareness Month August 22, 2025 Spinal Muscular Atrophy (SMA) is a rare genetic disorder that affects the motor neurons in the spinal cord, leading to muscle weakness and loss of movement. It impacts thousands of families worldwide, often striking in infancy or early childhood, though it can also appear in adulthood.  

2024 Global “AI in Oncology” market report August 21, 2025 🚀 Clinakos Inc. is proud to be recognized as a key player in shaping the future of AI-driven oncology alongside market leaders including Nvidia, ConcertAI, Oracle, PathAI, CureMatrix, @Tempus, GE Healthcare, Siemens Healthineers, Medrtonic, Roche, Insilico Medicone, and others.    According to the latest AI

Unlocking the Power of External Control Arms with Real-World Data August 7, 2025 A recent editorial in Frontiers in Drug Safety and Regulation highlights a major shift in clinical research: over 50% of single-arm HTA submissions between 2011 and 2019 included some form of external control data—a clear sign of ECAs’ growing importance for regulatory

Myth: “All patient data sources provide the same level of insight for research.” August 6, 2025 There’s a common myth floating around, and we are about to break that 🔨“Myth: All Patient Data Sources Offer Equal Insights” 🚫🔬   That’s simply NOT true.   In life sciences—especially in Rare Disease & Oncology—data quality isn’t just

World Lung Cancer Day August 5, 2025 On this World Lung Cancer Day, Clinakos Inc. stands with the fighters and survivors rewriting the narrative of lung cancer. 💪 Lung cancer is a complex and often misunderstood disease, but with our Integrated Patient Data™ and Medically Smart AI™, we’re transforming how real-world insights drive personalized care

The Predictive AI Surge in Healthcare July 31, 2025 🚀 Per a recent report, the global AI for predictive healthcare market is experiencing rapid growth—rising from $8.85B in 2024 to $11.69B in 2025, and projected to reach nearly $48B by 2030.    🤖 AI’s effectiveness is dependent on the quality of the data it is

Mayo Clinic Natural History Study July 29, 2025 The Mayo Clinic has launched a landmark natural history study focused on autosomal dominant leukodystrophy (ADLD), an ultra-rare hereditary neurodegenerative disorder. This initiative will collect deep, longitudinal data—medical records, imaging, genetics, and more—to better understand disease progression and accelerate new therapies for patients who urgently need them. 

AI Discovery in Drug Discovery and Clinical Trials July 24, 2025 AI is rapidly rewriting the rules for drug discovery and clinical trials. As highlighted in the latest Research and Markets report: 🧬 By 2025, 30% of new drugs will be discovered using AI, a seismic shift from traditional methods. ⏳ AI-enabled workflows can cut